Last reviewed · How we verify
Treatment with Apremilast — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Treatment with Apremilast (Treatment with Apremilast) — University of South Florida.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Treatment with Apremilast TARGET | Treatment with Apremilast | University of South Florida | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Treatment with Apremilast CI watch — RSS
- Treatment with Apremilast CI watch — Atom
- Treatment with Apremilast CI watch — JSON
- Treatment with Apremilast alone — RSS
Cite this brief
Drug Landscape (2026). Treatment with Apremilast — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-with-apremilast. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab